20 . April , 2018 - Friday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Ofloxacin

Big Image Pronouncation: (oh-FLOX-uh-SIN)
Class: Antibiotic, Fluoroquinolone

Trade Names:
Floxin Otic
- Solution, otic 3 mg/mL

Trade Names:
- Solution, ophthalmic 3 mg/mL

Trade Names:
- Tablets 200 mg
- Tablets 300 mg
- Tablets 400 mg

Apo-Oflox (Canada)

Mechanism of Action


Interferes with microbial DNA synthesis.



C max is 2.7 to 4 mcg/mL. T max is 1 to 2 h (oral).


Widely distributed to body tissues and fluids. 32% protein bound. Bioavailability is 98%.


Pyridobenzoxazine ring appears to decrease the extent of parent compound metabolism.


The t ½ is 4 to 5 hr (oral). Less than 5% is eliminated by the kidneys as desmethyl or N-oxide metabolites; 4% to 8% by feces.

Special Populations

Renal Function Impairment

Cl is reduced in patients with Ccr less than 50 mL/min. Dosage adjustment is necessary.


Longer plasma t ½ is approximately 6.4 to 7.4 h.

Indications and Usage

Treatment of acute bacterial exacerbations of chronic bronchitis, community acquired pneumonia, uncomplicated skin and skin structure infections, acute uncomplicated urethral and cervical gonorrhea, nongonococcal urethritis, cervicitis, acute pelvic inflammatory disease, uncomplicated cystitis, complicated UTI, prostatitis caused by Escherichia coli .


Treatment of conjunctivitis and corneal ulcer infections caused by susceptible organisms.


Treatment of otitis externa, chronic suppurative otitis media in patients with perforated tympanic membranes, and acute otitis media in children with tympanostomy tubes.


Standard considerations.


Epithelial herpes simplex keratitis; vaccinia; varicella; fungal disease of ocular structure; mycobacterial infections of the eye.

Dosage and Administration

Acute Otitis Media in Children with Tympanostomy Tubes
Children 1 to 12 yr of age

Otic 5 gtt (0.25 mL, 0.75 mg ofloxacin) instilled into affected ear twice daily for 10 days.

Acute Pelvic Inflammatory Disease

PO 400 mg every 12 h for 10 to 14 days.

Acute Uncomplicated Urethral and Cervical Gonorrhea

PO 400 mg as single dose.

Bacterial Conjunctivitis
Adults and Children 1 yr of age or older

Ophthalmic Days 1 and 2 instill 1 to 2 gtt every 2 to 4 h in affected eye(s). Days 3 through 7 instill 1 to 2 gtt 4 times daily.

Bacterial Corneal Ulcer
Adults and Children 1 yr of age or older

Ophthalmic Days 1 and 2 instill 1 to 2 gtt into affected eye every 30 min while awake, awaken at approximately 4 to 6 h after retiring and instill 1 to 2 gtt; days 3 through 7 to 9 instill 1 to 2 gtt every h while awake; days 7 to 9 instill 1 to 2 gtt 4 times daily.


PO 300 mg every 12 h for 7 days.

Chronic Bronchitis, Community-Acquired Pneumonia, Uncomplicated Skin and Skin Structure Infections

PO 400 mg every 12 h for 10 days.

Chronic Suppurative Otitis Media with Perforated Tympanic Membranes
Adults and children 12 yr of age and older

Otic 10 gtt (0.5 mL, 1.5 mg ofloxacin) instilled into affected ear twice daily for 10 days.

Complicated UTI

PO 200 mg every 12 h for 10 days.


PO 300 mg twice daily for 10 days.

Otitis Externa
Adults and children 12 yr of age and older

Otic 10 gtt (0.5 mL, 1.5 mg ofloxacin) instilled into affected ear twice daily for 10 days.

Children 1 to 12 yr of age

Otic 5 gtt (0.25 mL, 0.75 mg ofloxacin) instilled into affected ear twice daily for 10 days.


PO 300 mg every 12 h for 6 wk.

Uncomplicated Cystitis Caused by E. Coli or Klebsiella Pneumoniae

PO 200 mg every 12 h for 3 days.

Uncomplicated Cystitis Caused by Other Pathogens

PO 200 mg every 12 h for 7 days.


Store at 59° to 86°F. Protect from light.

Drug Interactions

Antacids, didanosine, iron salts, sucralfate, zinc salts

May decrease oral absorption of ofloxacin.

Antineoplastic agents

Serum ofloxacin levels may be decreased.


Coadministration with ofloxacin may increase risk of CNS stimulation and seizures.


Plasma levels of procainamide may be elevated, increasing the risk of toxicity.


Decreased Cl and increased plasma levels of theophylline may result in toxicity.

Laboratory Test Interactions

None well documented.

Adverse Reactions


Chest pain.


Dizziness, vertigo (1%, otic); headache; dizziness; fatigue; lethargy; drowsiness; insomnia; nervousness.


Pruritus, rash (4%, otic); rash, pruritus.


Tearing, dryness, eye pain, visual disturbances, transient burning, itching, stinging, inflammation, facial edema (ophthalmic); earache (otic).


Taste perversion (7%, otic); diarrhea; nausea; vomiting; abdominal pain or discomfort; dry or painful mouth; flatulence; dysgeusia.


Vaginal discharge; genital pruritus.


Eosinophilia; lymphocytopenia.


Increased ALT, AST.


Application site reaction (3%), paresthesia (otic); vaginitis; fever; decreased appetite. Ophthalmic use may possibly cause same adverse reactions seen with systemic use because of absorption.



Category C .


Excreted in breast milk.


Safety and efficacy not established in children younger than 1 yr of age. Safety and efficacy not established in children younger than 18 yr of age (otic).


Serious and occasionally fatal reactions (eg, anaphylactic) have occurred, some after the first dose.

Renal Function

Reduced Ccr may occur; decrease dose accordingly.


May result in bacterial or fungal overgrowth of nonsusceptible microorganisms.


Moderate to severe reactions may occur; avoid excessive sunlight and ultraviolet light.

Convulsions/Toxic psychosis

CNS stimulation can occur; use drug with caution in patients with known or suspected CNS disorders.

Pseudomembranous colitis

Consider possibility in patients who develop diarrhea.


Not effective for treating syphilis.


Inflammation and rupture of tendons have been associated with the use of fluoroquinolone antibiotics.



Nausea, dizziness, crystalluria, facial swelling and numbness, vomiting, drowsiness, hot and cold flushes.

Patient Information

  • Instruct patient to avoid taking antacids, sucralfate, vitamins with iron or minerals within 2 h before or 2 h after dose.
  • Advise diabetic patient to discontinue and notify health care provider if a hypoglycemic reaction occurs.
  • Encourage patient to drink fluids liberally.
  • Caution patient to avoid exposure to sunlight, and to use sunscreen or wear protective clothing to avoid photosensitivity reaction.
  • Advise patient to notify health care provider of signs of superinfection.
  • Caution patient to report the following symptoms to health care provider: seizures, nausea, rash, itching, diarrhea, shortness of breath, dizziness, headache.
  • Instruct patient to complete full course of therapy, even if symptoms have resolved.
  • Instruct patient to stop treatment and inform health care provider if experiencing pain, inflammation, or rupture of tendon, and to rest or refrain from exercise until diagnosis of tendonitis or tendon rupture is excluded.
  • Ophthalmic
  • Demonstrate and observe correct technique for instillation of ophthalmic drops.
  • Advise patient using ophthalmic solution to discontinue medication and notify health care provider of rash or allergic reaction.
  • Otic
  • Caution patient to avoid contaminating the applicator tip with material from fingers or other sources.
  • Instruct patient to warm the solution by holding the bottle in the hand for 1 or 2 min to avoid dizziness, which may result from the instillation of cold solution.

Recent Drug Updates at DrugIndexOnline:

Carbinoxamine Compound-Drops Carbinoxamine Compound-Drops
Some commonly used brand names are: In the U.S.— Alka-Seltzer Plus Cold and Cough 21 Alka-Seltzer Plus Cold and Cough Medicine Liqui-Gels 34 Alka-Seltzer Plus Night-Time Cold Liqui-Gels 35 Ami-Tex LA 69 Anatuss LA 70 Benylin Expectorant 54 Bromfed-DM 17 Broncholate 68 Carbinoxamine Compou more...

Cardiolite Cardiolite
Generic Name: Technetium Tc99m Sestamibi Dosage Form: Kit for the preparation of injection Cardiolite Description Each 5 mL vial contains a sterile, non-pyrogenic, lyophilized mixture of: Tetrakis (2-methoxy isobutyl isonitrile) Copper (I) tetrafluoroborate - 1.0 mg Sodium Citrate Dihydrate - more...

DynaCirc DynaCirc
Some commonly used brand names are: In the U.S.— Adalat 8 Adalat CC 8 Calan 10 Calan SR 10 Cardene 7 Cardizem 3 Cardizem CD 3 Cardizem LA 3 Cardizem SR 3 Dilacor-XR 3 DynaCirc 6 Isoptin 10 Isoptin SR 10 Nimotop 9 Norvasc 1 Plendil 4 Procardia 8 Procardia XL 8 Vascor 2 Verelan 10 Verelan P more...

Femcare Femcare
Generic Name: clotrimazole vaginal (kloe TRIM a zole) Brand Names: Femcare, Gyne-Lotrimin, Mycelex-G What is Femcare (clotrimazole vaginal)? Clotrimazole is an antifungal medication. It prevents fungus from growing. Clotrimazole vaginal is used to treat vaginal candida (yeast) infection more...

Guaifenesin DM Elixir Guaifenesin DM Elixir
Generic Name: Dextromethorphan/Guaifenesin Elixir, Liquid, Solution, or Syrup (DEX-troe-meth-OR-fan/gwye-FEN-e-sin) Brand Name: Examples include Guaifenesin DM and Tussi-Organidin-DMGuaifenesin DM Elixir is used for:Temporarily relieving cough due to the common cold, upper respiratory tract inf more...

Hydrochlorothiazide/Propranolol Hydrochlorothiazide/Propranolol
Generic Name: Hydrochlorothiazide/Propranolol (HYE-droe-KLOR-oh-THYE-a-zide/proe-PRAN-oh-lole) Brand Name: InderideDo not suddenly stop taking Hydrochlorothiazide/Propranolol without talking with your doctor. If Hydrochlorothiazide/Propranolol needs to be stopped by your doctor, this will be d more...

Ibu-6 Ibu-6
Some commonly used brand names are: In the U.S.— Actron 9 Advil 7 Advil Caplets 7 Advil, Children's 7 Aleve 14 Anaprox 14 Anaprox DS 14 Ansaid 6 Bayer Select Ibuprofen Pain Relief Formula Caplets 7 Cataflam 1 Clinoril 18 Cotylbutazone 16 Cramp End 7 Daypro 15 Dolgesic 7 Dolobid 2 EC-Napro more...

Pannaz Pannaz
Generic Name: carbinoxamine, methscopolamine, and pseudoephedrine (car bin OX uh meen, meth sko PAW luh meen, and soo doh ee FED rin) Brand Names: Pannaz, Pannaz S What is Pannaz (carbinoxamine, methscopolamine, and pseudoephedrine)? Carbinoxamine and methscopolamine are antihistamines more...